Literature DB >> 33232284

Loss of FBP1 promotes proliferation, migration, and invasion by regulating fatty acid metabolism in esophageal squamous cell carcinoma.

Yi He1, Rong Hua1, Bin Li1, Haiyong Gu1, Yifeng Sun1, Zhigang Li1.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers in China. Recent studies have shown fatty acid metabolism is involved in the progression of various cancers through regulating the function of various types of cells. However, the relationship between fatty acid metabolism and tumorigenesis of ESCC remains unclear. Here, in this study, the expression of FBP1 was dramatically decreased in ESCC tissues compared with the adjacent non-ESCC tissues. The cell proliferation, migration, invasion and fatty acid metabolism were evaluated in ESCC cells using transfection of shFBP1 vectors. We found loss of FBP1 promoted ESCC cell proliferation, migration and invasion, which correlated with the activated fatty acid metabolism in vitro. Moreover, the content of phospholipids, triglycerides, neutral lipids and the protein expression levels of fatty acid metabolism related FASN, ACC1 and SREBP1C proteins were significantly increased following down-regulation of FBP1. Furthermore, FBP1 was found to be directly targeted by miR-18b-5p in ESCC cells. In addition, miR-18b-5p inhibitor treatment obviously reversed the increased fatty acid metabolism induced by loss of FBP1 in ESCC cells. These findings explored a detailed molecular mechanism of tumorigenesis and progression of ESCC and might provide a potential novel method to treat ESCC in clinic.

Entities:  

Keywords:  ESCC; FBP1; fatty acid metabolism; miR-18b-5p; proliferation

Mesh:

Substances:

Year:  2020        PMID: 33232284      PMCID: PMC7950246          DOI: 10.18632/aging.103916

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  46 in total

1.  Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy.

Authors:  Qi Long; Brent A Johnson; Adeboye O Osunkoya; Yu-Heng Lai; Wei Zhou; Mark Abramovitz; Mingjing Xia; Mark B Bouzyk; Robert K Nam; Linda Sugar; Aleksandra Stanimirovic; Daron J Williams; Brian R Leyland-Jones; Arun K Seth; John A Petros; Carlos S Moreno
Journal:  Am J Pathol       Date:  2011-05-03       Impact factor: 4.307

Review 2.  Esophageal cancer in high-risk areas of China: research progress and challenges.

Authors:  Yingsong Lin; Yukari Totsuka; Baoen Shan; Chaochen Wang; Wenqiang Wei; Youlin Qiao; Shogo Kikuchi; Manami Inoue; Hideo Tanaka; Yutong He
Journal:  Ann Epidemiol       Date:  2016-11-25       Impact factor: 3.797

3.  The FOXC1/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect.

Authors:  Qingguo Li; Ping Wei; Jitao Wu; Meng Zhang; Guichao Li; Yaqi Li; Ye Xu; Xinxiang Li; Dacheng Xie; Sanjun Cai; Keping Xie; Dawei Li
Journal:  Oncogene       Date:  2018-08-31       Impact factor: 9.867

4.  Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.

Authors:  Hiroshi Saeki; Satoshi Tsutsumi; Hirotada Tajiri; Takafumi Yukaya; Ryosuke Tsutsumi; Sho Nishimura; Yu Nakaji; Kensuke Kudou; Shingo Akiyama; Yuta Kasagi; Ryota Nakanishi; Yuichiro Nakashima; Masahiko Sugiyama; Kippei Ohgaki; Hideto Sonoda; Eiji Oki; Yoshihiko Maehara
Journal:  Ann Surg       Date:  2017-03       Impact factor: 12.969

5.  Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells.

Authors:  Yue-Yue Wang; Lei Yan; Shuo Yang; He-Nan Xu; Tian-Tian Chen; Zheng-Yuan Dong; Su-Lian Chen; Wen-Rui Wang; Qing-Ling Yang; Chang-Jie Chen
Journal:  J Cell Physiol       Date:  2019-06-19       Impact factor: 6.384

6.  Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.

Authors:  Chenfang Dong; Tingting Yuan; Yadi Wu; Yifan Wang; Teresa W M Fan; Sumitra Miriyala; Yiwei Lin; Jun Yao; Jian Shi; Tiebang Kang; Pawel Lorkiewicz; Daret St Clair; Mien-Chie Hung; B Mark Evers; Binhua P Zhou
Journal:  Cancer Cell       Date:  2013-02-28       Impact factor: 31.743

7.  Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma.

Authors:  Marina Bárcena-Varela; Stefano Caruso; Susana Llerena; Gloria Álvarez-Sola; Iker Uriarte; M Ujue Latasa; Raquel Urtasun; Sandra Rebouissou; Laura Alvarez; Maddalen Jimenez; Eva Santamaría; Carlos Rodriguez-Ortigosa; Giuseppe Mazza; Krista Rombouts; Edurne San José-Eneriz; Obdulia Rabal; Xabier Agirre; Maria Iraburu; Alvaro Santos-Laso; Jesus M Banales; Jessica Zucman-Rossi; Felipe Prósper; Julen Oyarzabal; Carmen Berasain; Matías A Ávila; Maite G Fernández-Barrena
Journal:  Hepatology       Date:  2019-01-04       Impact factor: 17.425

Review 8.  Achalasia and esophageal cancer: risks and links.

Authors:  Maura Torres-Aguilera; José María Remes Troche
Journal:  Clin Exp Gastroenterol       Date:  2018-09-06

9.  Fatty acids and cancer-amplified ZDHHC19 promote STAT3 activation through S-palmitoylation.

Authors:  Jixiao Niu; Yang Sun; Baoen Chen; Baohui Zheng; Gopala K Jarugumilli; Sarah R Walker; Aaron N Hata; Mari Mino-Kenudson; David A Frank; Xu Wu
Journal:  Nature       Date:  2019-08-28       Impact factor: 49.962

10.  FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma.

Authors:  Bo Wang; Ping Fan; Jingyuan Zhao; Heyu Wu; Xin Jin; Heshui Wu
Journal:  J Exp Clin Cancer Res       Date:  2018-09-10
View more
  2 in total

1.  Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma.

Authors:  Alexander Damanakis; Patrick Sven Plum; Florian Gebauer; Wolfgang Schröder; Reinhard Büttner; Thomas Zander; Christiane Josephine Bruns; Alexander Quaas
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-27       Impact factor: 4.322

Review 2.  Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review.

Authors:  Meng-Ying Cui; Xing Yi; Zhen-Zhen Cao; Dan-Xia Zhu; Jun Wu
Journal:  J Oncol       Date:  2022-09-05       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.